John Devane
Dr Devane has been the chief executive officer of AGI since he founded the company in 2003 and was the founder and chief executive officer of Athpharma Limited from 2001 to 2005. Prior to this, Dr Devane worked in a number of roles in research and development, clinical and regulatory affairs and product development for Élan Corporation plc (1981-2001) and its subsidiary companies including executive vice president, R&D, Élan Drug Delivery (1996-2001); vice president, R&D, Élan Corporation plc (1993-1996); vice president, regulatory & clinical affairs, Élan Pharma USA (1990-1993) and director, product development, Élan Corporation plc (1987-1990).
Dr Devane studied pharmacology at University College Dublin and received his BSc (hons) in 1978 and was conferred with a Ph.D in 1982, also from UCD. Dr Devane holds a certified diploma in accounting and finance (Association of Certified Accountants), has numerous publications in the scientific area, including authorship of a number of book chapters, and has been an invited speaker at international scientific/ technical conferences.
